FIELD: medicinal microbiology. SUBSTANCE: invention relates to preparing probiotic strains. Cells of the strain Bacillus licheniformis 31 are transformed with plasmid pBMB 105 and a new recombinant strain Bacillus licheniformis 2336/105 is obtained. This strain is harmless for warm-blooded animals, it is able to inhibit pathogenic and opportunistic microflora and to produce alpha-2-interferon under microaerophilic conditions in the amount 102 IU/mg. Constructed strain can be used as a base for the new probiotic anti-infectious preparation. EFFECT: new strain indicated above, increased yield of alpha-2-interferon. 6 tbl, 4 ex
Authors
Dates
2001-08-20—Published
1998-06-30—Filed